Please login to the form below

Not currently logged in
Email:
Password:

ICS

This page shows the latest ICS news and features for those working in and with pharma, biotech and healthcare.

Sanofi's Dupixent gains asthma approval in Europe

Sanofi's Dupixent gains asthma approval in Europe

inflammation. However, Dupixent can only be used in this setting when patients have used at least one other maintenance treatment, along with high dose inhaled corticosteroid (ICS).

Latest news

More from news
Approximately 1 fully matching, plus 27 partially matching documents found.

Latest Intelligence

  • NHS regional footprints NHS regional footprints

    CCGs in action. In Nottinghamshire, six CCGs have joined forces to lead the strategic development of integrated care within the geographical area originally allocated to the Nottinghamshire ICS.

  • Deal Watch table for August 2014 Deal Watch table for August 2014

    600. TARIS Biomedical/ Allergan. Company acquisition. LiRIS for interstitial cystitis / bladder pain syndrome (IC/BPS) (phase II).

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics